Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand AI-Powered Heart Imaging for Children

Ventripoint Diagnostics Ltd., a pioneer in advanced cardiac imaging, announced a strategic collaboration with the Ollie Hinkle Heart Foundation (OHHF) to expand access to AI-powered cardiac imaging for children and adults with congenital and childhood-onset heart disease. The partnership leverages Ventripoint's VMS+™ platform, which uses artificial intelligence to generate accurate heart measurements from standard echocardiograms, and OHHF's Take Heart Collective Impact Model, which unites healthcare providers, innovators, researchers, families, and social partners such as Jovie's Joy and Ella's Umbrella.

Under the collaboration, OHHF will provide initial financial support to place two VMS+™ systems within its healthcare partner network. The initiative also includes opportunities for education, advocacy, research, technology adoption, and community engagement. The VMS+™ platform enhances clinical decision-making and patient monitoring by delivering sophisticated cardiac insights in a more accessible and efficient manner, potentially reducing barriers to advanced cardiac assessment.

Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint Diagnostics, emphasized the importance of accurate and affordable imaging: "Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging." He noted that OHHF has become a leader in bringing together various stakeholders to solve complex challenges, and together they aim to expand access to advanced imaging solutions.

The partnership is deeply rooted in the lived experiences of families. Katie Nesselbush, Founder of Jovie's Joy, shared her perspective as a mother of a child with dilated cardiomyopathy: "As a mother of a child living with dilated cardiomyopathy, I know firsthand the impossible decisions families can face when trying to get answers about their child's heart." She highlighted that technologies like Ventripoint provide physicians with more information to guide care while reducing barriers and risk for families.

Mark Hinkle, Co-Founder of OHHF, reflected on the personal tragedy that inspired the foundation: "When our son Ollie passed away at just 13 months old, we learned firsthand how quickly a child's condition can change." He added that the goal is to ensure more children have access to technology and treatment options that Ollie and others did not. The collaboration aims to honor children like Ollie and Ella by building a future where advanced imaging is widely available.

Ventripoint Diagnostics Ltd. is recognized as an industry leader in applying AI to echocardiography, with its VMS products using proprietary Knowledge Based Reconstruction technology to provide accurate volumetric cardiac measurements equivalent to MRI. This affordable alternative enables cardiologists to manage patients with greater confidence. For more information, visit www.ventripoint.com.

The Ollie Hinkle Heart Foundation transforms pediatric heart care through its Take Heart Collective Impact Model, aligning various stakeholders to accelerate innovation and address unmet needs. Further details are available at www.ohhf.org.